Jupiter Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $2.32M | Sell |
48,442
-35,275
| -42% | -$1.69M | 0.04% | 238 |
|
|
2020
Q1 | $3.85M | Sell |
83,717
-6,407
| -7% | -$295K | 0.08% | 170 |
|
|
2019
Q4 | $5.41M | Hold |
90,124
| – | – | 0.08% | 217 |
|
|
2019
Q3 | $5.1M | Buy |
90,124
+33,027
| +58% | +$1.87M | 0.07% | 237 |
|
|
2019
Q2 | $3.18M | Buy |
+57,097
| New | +$3.18M | 0.03% | 211 |
|
|
2018
Q4 | – | Sell |
-18,494
| Closed | -$1.28M | – | 456 |
|
|
2018
Q3 | $1.28M | Hold |
18,494
| – | – | 0.01% | 249 |
|
|
2018
Q2 | $1.4M | Sell |
18,494
-326,560
| -95% | -$24.7M | 0.01% | 257 |
|
|
2018
Q1 | $18.2M | Sell |
345,054
-36,708
| -10% | -$1.93M | 0.14% | 128 |
|
|
2017
Q4 | $20.4M | Sell |
381,762
-4,370
| -1% | -$233K | 0.19% | 112 |
|
|
2017
Q3 | $23M | Buy |
386,132
+282,225
| +272% | +$16.8M | 0.24% | 109 |
|
|
2017
Q2 | $8.2M | Buy |
+103,907
| New | +$8.2M | 0.1% | 145 |
|